| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/11/2013 | CN101909639B Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 09/11/2013 | CN101830955B Synthesizing process of antineoplastic agent clofarabine |
| 09/11/2013 | CN101817769B Carbamido peptide aminopeptidase N inhibitor and application thereof |
| 09/11/2013 | CN101735991B Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 09/11/2013 | CN101686971B Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 09/11/2013 | CN101679439B P70 s6激酶抑制剂 P70 s6 kinase inhibitors |
| 09/11/2013 | CN101628863B New compounds separated from leaves of rubus corchorifolius and preparation method and application thereof |
| 09/11/2013 | CN101525385B Screening and preparation method and application for antibody medicament for malignant lymphoma and autoimmune diseases |
| 09/11/2013 | CN101516870B Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 09/11/2013 | CN101478991B Tc-99m nano tin colloid and preparation thereof |
| 09/11/2013 | CN101367793B Amino-quinazoline derivative with antineoplastic activity and salts thereof |
| 09/10/2013 | US8530659 Pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment |
| 09/10/2013 | US8530505 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/10/2013 | US8530485 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 09/10/2013 | US8530456 Sonic hedgehog modulators |
| 09/10/2013 | US8530448 Compounds and methods for inhibiting selectin-mediated function |
| 09/10/2013 | US8530438 Vivo production of small interfering RNAs that mediate gene silencing |
| 09/10/2013 | US8530431 Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides |
| 09/10/2013 | US8530429 Brain tumor targeting peptides and methods |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8529905 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/10/2013 | US8529904 Antigenic peptide comprising sequenc simimlarity to wilm's tumor-1 gene a nd gata-1 transcription factor for use as targeting tools in treatment of cell proliferative disorders; tissue targeted therapy |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | CA2764542C Disubstituted phthalazine hedgehog pathway antagonists |
| 09/10/2013 | CA2747420C Azaazulene compounds |
| 09/10/2013 | CA2723396C Benzene sulfonamide thiazole and oxazole compounds |
| 09/10/2013 | CA2700690C Process for producing reformatsky reagent in stable form |
| 09/10/2013 | CA2669687C Phthalazine derivatives |
| 09/10/2013 | CA2650572C Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/10/2013 | CA2602199C Heteroaryl urea derivatives useful for inhibiting chk1 |
| 09/10/2013 | CA2588278C Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 09/10/2013 | CA2585934C Novel pyrazolopyridine urea kinase inhibitors |
| 09/10/2013 | CA2581316C Substituted chroman derivatives, medicaments and use in therapy |
| 09/10/2013 | CA2531173C Equol-producing lactic acid bacteria-containing composition |
| 09/10/2013 | CA2529056C Combinations of tumor-associated antigens in compositions for various types of cancers |
| 09/10/2013 | CA2513398C Antisense oligonucleotides that inhibit expression of hif-1 |
| 09/10/2013 | CA2458627C Human cdr-grafted antibody and antibody fragment thereof |
| 09/10/2013 | CA2431964C Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 09/10/2013 | CA2427340C Cyp1b1 nucleic acids and methods of use |
| 09/10/2013 | CA2413237C Alteration of cell membrane for new functions |
| 09/10/2013 | CA2331789C Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 09/08/2013 | CA2770773A1 Novel method for analyzing circulating tumor cells of a patient for the presence of metastasis-initiating cells |
| 09/06/2013 | WO2013131105A1 Synergistic anti-proliferation activity of tas-108 with mtor inhibitors against cancer cells |
| 09/06/2013 | WO2013131093A1 The use of a panel of urinary cytokines to predict response to bcg therapy for bladder cancer |
| 09/06/2013 | WO2013131019A1 Iaspp phosphorylation and metastatic potential |
| 09/06/2013 | WO2013131000A1 Emt-inducing transcription factors cooperate with sox9 |
| 09/06/2013 | WO2013130976A1 Serine/threonine kinase inhibitors |
| 09/06/2013 | WO2013130905A1 Antibodies to matrix metalloproteinase 9 |
| 09/06/2013 | WO2013130811A1 Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists |
| 09/06/2013 | WO2013130775A1 Methods for treating patients undergoing multi-cycle chemotherapy |
| 09/06/2013 | WO2013130725A1 Trioxane thioacetal monomers and dimers and methods of use thereof |
| 09/06/2013 | WO2013130660A1 Amides as pim inhibitors |
| 09/06/2013 | WO2013130603A1 Ganglioside gd2 as a marker and target on cancer stem cells |
| 09/06/2013 | WO2013130600A1 Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith |
| 09/06/2013 | WO2013130407A1 Small molecule inhibitors of p-type atpases |
| 09/06/2013 | WO2013130358A1 Macrocyclic compounds |
| 09/06/2013 | WO2013130242A1 Geranylgeranylacetone formulations |
| 09/06/2013 | WO2013130013A1 Novel compounds and uses thereof |
| 09/06/2013 | WO2013129935A1 Use of a particulate immunomodulator in cancer therapy |
| 09/06/2013 | WO2013129879A1 Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same |
| 09/06/2013 | WO2013128288A1 Monomeric bacterial actin adp-ribosyltransferases as cancer chemotherapeutics |
| 09/06/2013 | WO2013128029A1 Pharmaceutically active pyrazolo-triazine derivatives |
| 09/06/2013 | WO2013128028A1 Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors |
| 09/06/2013 | WO2013127885A1 A conjugate of methotrexate and hydroxyethyl starch for use in the treatment cancer |
| 09/06/2013 | WO2013127361A1 Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers |
| 09/06/2013 | WO2013127269A1 Amido spirocyclic amide and sulfonamide derivatives |
| 09/06/2013 | WO2013127268A1 Amido-benzyl sulfone and sulfonamide derivatives |
| 09/06/2013 | WO2013127267A1 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
| 09/06/2013 | WO2013127266A1 Amido-benzyl sulfone and sulfoxide derivatives |
| 09/06/2013 | WO2013127011A1 Reprogramming effector protein interactions to correct epigenetic defects in cancer |
| 09/06/2013 | WO2013126993A1 Screening assays for identifying and validating agents that target cancer stem cells |
| 09/06/2013 | WO2013126962A1 Therapeutic and diagnostic agents |
| 09/06/2013 | WO2013106646A3 Compounds and methods for the inhibition of vcb e3 ubiquitin ligase |
| 09/06/2013 | WO2013082511A9 Methods for overcoming tumor resistance to vegf antagonists |
| 09/06/2013 | WO2013059433A3 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
| 09/05/2013 | US20130230600 Therapeutic agent |
| 09/05/2013 | US20130230501 Cycloalkyl-Substituted Imidazole Derivative |
| 09/04/2013 | EP2634581A1 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 09/04/2013 | EP2634196A1 Anti-mesothelin antibodies and uses therefor |
| 09/04/2013 | EP2634194A1 Anti-cdh3 antibody having high internalization capacity |
| 09/04/2013 | EP2634190A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors |
| 09/04/2013 | EP2634189A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
| 09/04/2013 | EP2634178A1 Quinazoline derivative and quinazoline complex protein kinase inhibitor for inhibiting multiplication of tumor cells and preparation method thereof |
| 09/04/2013 | EP2634176A1 Pyridine derivative and medicinal agent |
| 09/04/2013 | EP2634173A1 Polymorph of n-(6-(4-chlorophenoxy)hexyl)-n'-cyano-n''-(4-pyridyl)guanidine, and preparation therefor and use thereof |
| 09/04/2013 | EP2633866A2 Combination therapy |
| 09/04/2013 | EP2633861A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 09/04/2013 | EP2633858A2 Small molecules that replace or agonize p53 function |
| 09/04/2013 | EP2633856A2 ATP citrate lyase inhibitors for treating cancer |
| 09/04/2013 | EP2632954A1 Means and methods for treating dlbcl |
| 09/04/2013 | EP2632939A2 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 09/04/2013 | EP2632933A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases |
| 09/04/2013 | EP2632926A1 Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin iii |
| 09/04/2013 | EP2632923A1 Quinazoline derivatives |
| 09/04/2013 | EP2632921A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl]methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders |
| 09/04/2013 | EP2632920A1 Sulfonamides for the modulation of pkm2 |
| 09/04/2013 | EP2632916A1 Novel anti-cancer agents |
| 09/04/2013 | EP2632912A2 Anti-cancer serine hydrolase inhibitory carbamates |
| 09/04/2013 | EP2632903A2 Metalloenzyme inhibitor compounds |